CLARITEV CORPORATION (CTEV) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.92%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.92% | Share-based compensation / revenue. Period ending 2026-06-30. $29.06M ÷ $994.67M × 100 ≈ 2.92% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 994.67M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 29.06M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 32.49M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $994.67M | $29.06M | $32.49M | (m) | (m) | 2.92% | (m) | (m) |
| 2026-03-31 | (m) | $978.76M | $28.39M | $25.66M | (m) | (m) | 2.90% | (m) | (m) |
| 2025-12-31 | (m) | $965.41M | $27.82M | $28.77M | (m) | (m) | 2.88% | (m) | (m) |
| 2025-09-30 | (m) | $951.00M | $26.84M | $-4.97M | (m) | (m) | 2.82% | (m) | (m) |
| 2025-06-30 | (m) | $935.54M | $26.67M | $-353.25M | (m) | (m) | 2.85% | (m) | (m) |
| 2025-03-31 | (m) | $927.45M | $27.28M | $-893.75M | (m) | (m) | 2.94% | (m) | (m) |
| 2024-12-31 | (m) | $930.62M | $26.64M | $-1.39B | (m) | (m) | 2.86% | (m) | (m) |
| 2024-09-30 | (m) | $942.61M | $24.49M | $-1.31B | (m) | (m) | 2.60% | (m) | (m) |
| 2024-06-30 | (m) | $954.92M | $22.51M | $-930.03M | (m) | (m) | 2.36% | (m) | (m) |
| 2024-03-31 | (m) | $959.44M | $20.02M | $-371.40M | $331.98M | (m) | 2.09% | -1.12× | Reported |
| 2023-12-31 | (m) | $961.52M | $18.02M | $161.98M | $333.21M | (m) | 1.87% | 0.49× | Reported |
| 2023-09-30 | (m) | $958.48M | $18.80M | $-492.37M | $332.38M | (m) | 1.96% | -1.48× | Reported |
| 2023-06-30 | (m) | $966.13M | $18.03M | $-495.49M | $325.16M | (m) | 1.87% | -1.52× | Reported |
| 2023-03-31 | (m) | $1.02B | $17.30M | $-432.42M | $315.38M | (m) | 1.70% | -1.37× | Reported |
| 2022-12-31 | (m) | $1.08B | $16.74M | $-362.73M | $303.40M | (m) | 1.55% | -1.20× | Reported |
| 2022-09-30 | (m) | $1.14B | $16.11M | $360.40M | $293.47M | (m) | 1.42% | 1.23× | Reported |
| 2022-06-30 | (m) | $1.17B | $16.80M | $428.46M | $283.89M | (m) | 1.43% | 1.51× | Reported |
| 2022-03-31 | (m) | $1.16B | $20.17M | $420.49M | $275.20M | (m) | 1.74% | 1.53× | Reported |
| 2021-12-31 | (m) | $1.12B | $18.01M | $386.12M | $267.48M | (m) | 1.61% | 1.44× | Reported |
| 2021-09-30 | (m) | $1.07B | $119.62M | $236.31M | $271.58M | (m) | 11.13% | 0.87× | Reported |
| 2021-06-30 | (m) | $1.01B | $377.22M | $-67.64M | $286.34M | (m) | 37.35% | -0.24× | Reported |
| 2021-03-31 | (m) | $940.61M | $397.66M | $-137.17M | $308.39M | (m) | 42.28% | -0.44× | Reported |
| 2020-12-31 | (m) | $937.76M | $406.05M | $-131.82M | $335.64M | (m) | 43.30% | -0.39× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $982.90M | $-14.88M | $368.21M | $376.35M | (m) | -1.51% | 0.98× | Reported |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.04B | $4.72M | $427.54M | $383.26M | (m) | 0.45% | 1.12× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rimini Street, Inc. (RMNI) | United States | $0.401B | 54.39 |
| Advantage Solutions Inc. (ADV) | United States | $0.435B | -2.00 |
| International Money Express, Inc. (IMXI) | United States | $0.320B | 23.44 |
| Outdoor Holding Co (POWW) | United States | $0.270B | 40.73 |
| CONDUENT Inc (CNDT) | United States | $0.253B | -1.00 |
| DHI GROUP, INC. (DHX) | United States | $0.205B | 132.15 |
| Phreesia, Inc. (PHR) | United States | $0.621B | 63.46 |
| TEN Holdings, Inc. (XHLD) | United States | $0.152B | |
| Priority Technology Holdings, Inc. (PRTH) | United States | $0.643B | 9.77 |
| OptimizeRx Corp (OPRX) | United States | $0.149B | 23.33 |